TTR and cancer: reported that interleukin (IL)-8 and clinical symptoms were associated with prognosis in advanced patients with cancer and cachexia, and that serum albumin (Alb) and transthyretin (TTR) levels were significantly lower in patients with a short prognosis compared to those with a longer prognosis.4 Miura et al.